Amdocs (DOX) Common Equity (2009 - 2026)

Amdocs has disclosed Common Equity across 18 years of filings, most recently posting $3.4 billion for Q1 2026.

• In Q1 2026, Common Equity fell 2.25% year-over-year to $3.4 billion; the TTM figure through Mar 2026 stood at $3.4 billion (down 2.25% YoY), while the FY2025 annual figure was $3.5 billion, down 0.81% from the prior year.
• Common Equity declined to $3.4 billion in Q1 2026, from $3.5 billion in the prior quarter.
• Over the last five years, Common Equity for DOX reached as high as $3.7 billion in Q2 2023 and fell as low as $3.4 billion in Q1 2026.
• The 5-year median for Common Equity is $3.6 billion (2022), against an average of $3.5 billion.
• Annual changes were most pronounced in 2023 — Common Equity gained 2.21% — and 2024, when it retreated 2.89%.
• A 5-year view of Common Equity shows it stood at $3.6 billion in 2022, then increased by 0.35% to $3.6 billion in 2023, then dropped by 2.68% to $3.5 billion in 2024, then declined by 1.16% to $3.5 billion in 2025, then slipped by 1.2% to $3.4 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $3.4 billion, $3.5 billion, and $3.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.